This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Gatekeeper European 005

This study has been terminated.
Information provided by:
MedtronicNeuro Identifier:
First received: September 27, 2005
Last updated: July 24, 2008
Last verified: July 2008
Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04

Condition Intervention
GERD Device: Gatekeeper Reflux Repari System (Device)

Study Type: Observational
Official Title: Long Term Follow-up European Gatekeeper Study 005

Further study details as provided by MedtronicNeuro:

Estimated Enrollment: 55

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Subjects must have been part of the Endo 2000-03 or Endo 2000-04 clinical study
  • Subjects who have been informed of the nature of the long-term follow-up study and have agreed to its participation and provided Informed Consent

Exclusion Criteria:

  • Underwent another endoscopic or surgical treatment for GERD (except re-intervention with Gatekeeper)
  • Developed other medical illness that may cause the subject to be non-compliant
  • Extensive Barrett's Esophagus (>2 cm)
  • Unable or unwilling to cooperate with the study procedures
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00229086

United States, Minnesota
Contact Medtronic for specific site information
Minneapolis, Minnesota, United States, 44126
Contact Medtronic for specific location
Tolochenaz, Switzerland
Sponsors and Collaborators
Principal Investigator: Medtronic GU Investigator MedtronicNeuro
  More Information Identifier: NCT00229086     History of Changes
Other Study ID Numbers: MGU-004
Study First Received: September 27, 2005
Last Updated: July 24, 2008 processed this record on July 26, 2017